Literature DB >> 33310867

Forcing a growth factor response - tissue-stiffness modulation of integrin signaling and crosstalk with growth factor receptors.

Farhana A Sarker1,2, Victoria G Prior1,2, Samuel Bax1, Geraldine M O'Neill3,2,4.   

Abstract

Research throughout the 90s established that integrin crosstalk with growth factor receptors stimulates robust growth factor signaling. These insights were derived chiefly from comparing adherent versus suspension cell cultures. Considering the new understanding that mechanosensory inputs tune adhesion signaling, it is now timely to revisit this crosstalk in different mechanical environments. Here, we present a brief historical perspective on integrin signaling against the backdrop of the mechanically diverse extracellular microenvironment, then review the evidence supporting the mechanical regulation of integrin crosstalk with growth factor signaling. We discuss early studies revealing distinct signaling consequences for integrin occupancy (binding to matrix) and aggregation (binding to immobile ligand). We consider how the mechanical environments encountered in vivo intersect with this diverse signaling, focusing on receptor endocytosis. We discuss the implications of mechanically tuned integrin signaling for growth factor signaling, using the epidermal growth factor receptor (EGFR) as an illustrative example. We discuss how the use of rigid tissue culture plastic for cancer drug screening may select agents that lack efficacy in the soft in vivo tissue environment. Tuning of integrin signaling via external mechanical forces in vivo and subsequent effects on growth factor signaling thus has implications for normal cellular physiology and anti-cancer therapies.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cancer; Cell adhesion; EGFR; Integrin; Mechanosensing; Mechanotransduction

Year:  2020        PMID: 33310867     DOI: 10.1242/jcs.242461

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

Review 1.  Ligand functionalization of titanium nanopattern enables the analysis of cell-ligand interactions by super-resolution microscopy.

Authors:  Kashish Jain; Pakorn Kanchanawong; Michael P Sheetz; Xianjing Zhou; Haogang Cai; Rishita Changede
Journal:  Nat Protoc       Date:  2022-07-27       Impact factor: 17.021

2.  Substratum stiffness regulates Erk signaling dynamics through receptor-level control.

Authors:  Payam E Farahani; Sandra B Lemke; Elliot Dine; Giselle Uribe; Jared E Toettcher; Celeste M Nelson
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423

Review 3.  Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications.

Authors:  Jiajia Li; Liyao Peng; Qun Chen; Ziping Ye; Tiantian Zhao; Sicong Hou; Jianguo Gu; Qinglei Hang
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

Review 4.  Mechanical Properties of the Extracellular Environment of Human Brain Cells Drive the Effectiveness of Drugs in Fighting Central Nervous System Cancers.

Authors:  Mateusz Cieśluk; Katarzyna Pogoda; Ewelina Piktel; Urszula Wnorowska; Piotr Deptuła; Robert Bucki
Journal:  Brain Sci       Date:  2022-07-15

5.  Mechanosensitive expression of the mesenchymal subtype marker connective tissue growth factor in glioblastoma.

Authors:  Thomas James Grundy; Louise Orcheston-Findlay; Eshana de Silva; Thuvarahan Jegathees; Victoria Prior; Farhana Amy Sarker; Geraldine Margaret O'Neill
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

6.  Integrin α3β1 Represses Reelin Expression in Breast Cancer Cells to Promote Invasion.

Authors:  Abibatou Ndoye; Rakshitha Pandulal Miskin; C Michael DiPersio
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

Review 7.  Advanced Spheroid, Tumouroid and 3D Bioprinted In-Vitro Models of Adult and Paediatric Glioblastoma.

Authors:  Louise Orcheston-Findlay; Samuel Bax; Robert Utama; Martin Engel; Dinisha Govender; Geraldine O'Neill
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.